118 related articles for article (PubMed ID: 12866446)
1. [Therapy-related leukemia].
Yokozawa T; Naoe T
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1007-12. PubMed ID: 12866446
[No Abstract] [Full Text] [Related]
2. The impact of biology on the treatment of secondary AML.
Gojo I; Karp JE
Cancer Treat Res; 2001; 108():231-55. PubMed ID: 11702601
[No Abstract] [Full Text] [Related]
3. Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Hon C; Chan GC; Ha SY; Ma SK; Wong KF; Au WY
Ann Hematol; 2004 Jul; 83(7):481-3. PubMed ID: 15170522
[TBL] [Abstract][Full Text] [Related]
4. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
[TBL] [Abstract][Full Text] [Related]
5. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
[TBL] [Abstract][Full Text] [Related]
6. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II inhibitor-related acute myeloid leukaemia.
Pui CH; Relling MV
Br J Haematol; 2000 Apr; 109(1):13-23. PubMed ID: 10848777
[No Abstract] [Full Text] [Related]
8. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
[TBL] [Abstract][Full Text] [Related]
10. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.
Satake N; Ishida Y; Otoh Y; Hinohara S; Kobayashi H; Sakashita A; Maseki N; Kaneko Y
Genes Chromosomes Cancer; 1997 Sep; 20(1):60-3. PubMed ID: 9290955
[TBL] [Abstract][Full Text] [Related]
11. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
Daser A; Rabbitts TH
Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992
[No Abstract] [Full Text] [Related]
12. Molecular genetics of 11q23 chromosome translocations.
Canaani E; Nowell PC; Croce CM
Adv Cancer Res; 1995; 66():213-34. PubMed ID: 7793315
[No Abstract] [Full Text] [Related]
13. Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation.
Suehiro Y; Uike N; Kumagawa M; Goto T; Muta K; Kozuru M
Am J Hematol; 1997 Jul; 55(3):165-6. PubMed ID: 9256300
[No Abstract] [Full Text] [Related]
14. Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.
Nasr F; Macintyre E; Venuat AM; Bayle C; Carde P; Ribrag V
Leuk Lymphoma; 1997 Apr; 25(3-4):399-401. PubMed ID: 9168451
[TBL] [Abstract][Full Text] [Related]
15. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
Osaka M; Rowley JD; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6428-33. PubMed ID: 10339604
[TBL] [Abstract][Full Text] [Related]
16. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of occurrence of secondary tumors by antitumor drugs].
Andoh T
Gan To Kagaku Ryoho; 1999 Nov; 26(13):1988-98. PubMed ID: 10584562
[TBL] [Abstract][Full Text] [Related]
18. Infant leukaemia biology, aetiology and treatment.
Greaves MF
Leukemia; 1996 Feb; 10(2):372-7. PubMed ID: 8637251
[No Abstract] [Full Text] [Related]
19. Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
Jabali Y; Starý J; Hak J; Blazek B; Hrstkova H; Mihál V; Mydlil J; Timr P; Gajdos P
Med Pediatr Oncol; 2000 Nov; 35(5):493-5. PubMed ID: 11070483
[No Abstract] [Full Text] [Related]
20. Translocation (10;11)(p13;q13) and MLL gene rearrangement in a case of AML (M5a) with aggressive leukemia cutis.
Kubonishi I; Seto M; Murata N; Kamioka M; Taguchi H; Miyoshi I
Cancer Genet Cytogenet; 1998 Jul; 104(1):28-31. PubMed ID: 9648554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
